menu search

Travere therapeutics announces late-breaking data from phase 3 studies of sparsentan in igan and fsgs published in the lancet and the nejm respectively and presented at the american society of nephrol

Two-year results from both PROTECT and DUPLEX pivotal Phase 3 studies demonstrate treatment with sparsentan has the potential to preserve kidney funct...

November 3, 2023, 2:46 pm

Zenas biopharma announces publication of phase 2 study of obexelimab, an investigational treatment for igg4-related disease (igg4-rd), in the lancet rheumatology

Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active...

August 1, 2023, 12:23 pm

Elevar therapeutics announces publication of phase 3 cares 310 study results in the lancet

In CARES 310, camrelizumab plus rivoceranib demonstrated statistically significant and clinically meaningful prolonged overall survival and progressio...

July 25, 2023, 1:39 am

Eli lilly stuns doctors as obesity drug sparks 24% weight loss

A new drug to tackle obesity cut the weight of participants by an average of 58 pounds at the end of its latest clinical trial, US drug giant Eli Lill...

June 27, 2023, 4:01 am

Travere therapeutics announces interim analysis from the phase 3 protect study of filspariā„¢ (sparsentan) in iga nephropathy published in the lancet and presented at world congress of nephrology 2023

FILSPARI demonstrated a statistically significant, rapid, and sustained decline of proteinuria compared to the active control SAN DIEGO, April 01, 202...

April 1, 2023, 8:30 am

Is pfizer stock a buy after study reveals the need for booster shots?

On Tuesday, Pfizer Inc. (NYSE:PFE) shares edged slightly higher after The lancet published a report sho...

October 5, 2021, 1:22 pm

Is pfizer stock a buy after study reveals the need for booster shots?

On Tuesday, Pfizer Inc. (NYSE:PFE) shares edged slightly higher after The lancet published a report sho...

October 5, 2021, 1:22 pm

Is pfizer stock a buy after study reveals the need for booster shots?

On Tuesday, Pfizer Inc. (NYSE:PFE) shares edged slightly higher after The lancet published a report sho...

October 5, 2021, 1:22 pm

Is pfizer stock a buy after study reveals the need for booster shots?

On Tuesday, Pfizer Inc. (NYSE:PFE) shares edged slightly higher after The lancet published a report sho...

October 5, 2021, 1:22 pm

Is pfizer stock a buy after study reveals the need for booster shots?

On Tuesday, Pfizer Inc. (NYSE:PFE) shares edged slightly higher after The lancet published a report sho...

October 5, 2021, 1:22 pm

Is pfizer stock a buy after study reveals the need for booster shots?

On Tuesday, Pfizer Inc. (NYSE:PFE) shares edged slightly higher after The lancet published a report sho...

October 5, 2021, 1:22 pm

Is pfizer stock a buy after study reveals the need for booster shots?

On Tuesday, Pfizer Inc. (NYSE:PFE) shares edged slightly higher after The lancet published a report sho...

October 5, 2021, 1:22 pm

Pfizer covid-19 vaccine effectiveness wanes but the shot is good for keeping people out of hospitals, says study

Pfizer Inc (NYSE: PFE) and its partner BioNTech SE's (NASDAQ: BNTX) COVID-19 vaccine's effectiveness against the disease wanes with time but its prote...

October 5, 2021, 3:03 am

Pfizer covid-19 vaccine effectiveness wanes but the shot is good for keeping people out of hospitals, says study

Pfizer Inc (NYSE: PFE) and its partner BioNTech SE's (NASDAQ: BNTX) COVID-19 vaccine's effectiveness against the disease wanes with time but its prote...

October 5, 2021, 3:03 am

Pfizer covid-19 vaccine effectiveness wanes but the shot is good for keeping people out of hospitals, says study

Pfizer Inc (NYSE: PFE) and its partner BioNTech SE's (NASDAQ: BNTX) COVID-19 vaccine's effectiveness against the disease wanes with time but its prote...

October 5, 2021, 3:03 am

Pfizer covid-19 vaccine effectiveness wanes but the shot is good for keeping people out of hospitals, says study

Pfizer Inc (NYSE: PFE) and its partner BioNTech SE's (NASDAQ: BNTX) COVID-19 vaccine's effectiveness against the disease wanes with time but its prote...

October 5, 2021, 3:03 am

Pfizer covid-19 vaccine effectiveness wanes but the shot is good for keeping people out of hospitals, says study

Pfizer Inc (NYSE: PFE) and its partner BioNTech SE's (NASDAQ: BNTX) COVID-19 vaccine's effectiveness against the disease wanes with time but its prote...

October 5, 2021, 3:03 am

Pfizer covid-19 vaccine effectiveness wanes but the shot is good for keeping people out of hospitals, says study

Pfizer Inc (NYSE: PFE) and its partner BioNTech SE's (NASDAQ: BNTX) COVID-19 vaccine's effectiveness against the disease wanes with time but its prote...

October 5, 2021, 3:03 am

Pfizer covid-19 vaccine effectiveness wanes but the shot is good for keeping people out of hospitals, says study

Pfizer Inc (NYSE: PFE) and its partner BioNTech SE's (NASDAQ: BNTX) COVID-19 vaccine's effectiveness against the disease wanes with time but its prote...

October 5, 2021, 3:03 am

Pfizer covid shot protects people from hospitalization even as effectiveness against infection falls, lancet study confirms

Researchers found the effectiveness of Pfizer's vaccine against the delta variant was 93% a month after the second dose and fell to 53% after four mon...

October 4, 2021, 6:30 pm


Search within

Pages Search Results: